Browsing by Author "Senol, E"

Now showing 1 - 3 of 3
  • No Thumbnail Available
    Item
    Assessment of Lower Urinary Tract Symptoms and Sexual Function in Women with Metabolic Syndrome
    Borazan, S; Temeltas, G; Üçer, O; Hekimsoy, Z; Senol, E
    Objective To assess lower urinary tract symptoms and sexual function in premenopausal women with metabolic syndrome (MetS). Materials and Methods A total of 34 premenopausal patients over 18 years of age with MetS and who were admitted to our endocrinology clinic between September 2013 and April 2014 were included. Control group was consisted of 30 healthy controls chosen from the staff of the hospital. The sexual function, lower urinary tract symptoms and quality of life of the participants were evaluated by using Index of Female Sexual Function (IFSF), Urogenital Distress Inventory (UDI-6), and Incontinence Impact Questionnaire (IIQ-7), respectively. The scores of the patients were statistically compared with those of controls. Results The mean ages of the patient and control groups were 40.50 +/- 5.12 years and 38.17 +/- 2.12 years, respectively (p=0.09). The mean IFSF-total and all of the IFSF sub scales (except pain) in the patient group were significantly lower than those of the control group. The mean UDI-6 score of the patients was significantly higher than the controls (p=0.001). The mean IIQ-7 scores of the patients was higher than controls, however this increase was not statistically significant (p=0.11). Conclusion These findings showed that MetS affected adversely the sexual function of premenopausal women due to the fact that IFSF scores were found to be lower in women with MetS as compared to healthy controls. Moreover, IFSF score under the threshold values in patients showed that patients with MetS had sexual function disorder. These lower urinary tract symptoms in the patients with MetS did not affect the quality of life although the severity of lower urinary tract symptoms of patients with MetS was significantly worse than that in control group.
  • No Thumbnail Available
    Item
    Evaluation of visual pathways using visual evoked potentials in the patients with impaired fasting glucose and impaired glucose tolerance
    Korkmaz, T; Kisabay, A; Hekimsoy, Z; Senol, E; Selçuki, D
    Purpose: There are many studies on degeneration of the ganglion cells using visual evoked potential (VEP) in Diabetes mellitus (DM). The present study intended to investigate whether the retinopathy findings would be helpful for detecting the degeneration to develop or not in retinal ganglion cells with the VEP test before being detectable in ophthalmoscopic examination on prediabetic patients. Materials and methods: The present study was conducted prospectively after obtaining approval from the Ethics Committee. In our study, the subjects were divided into three groups as impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and normal patients. They also underwent physical, ophthalmological and VEP examination. Three main components of VEP obtained from these groups were N75, P100, and N145 latency and N75-P100 amplitude. Results: The study participants consisted of the IFG group (n: 30, female/male ratio: 21/9; mean age: 49.17 +/- 10.52 years), the IGT group (n: 30, female/male ratio: 23/7; mean age: 47.00 +/- 11.09 years), and the Control Group (n: 40, female/male ratio: 30/10; mean age: 48.03 +/- 10.96 years). Difference in sex and age between the study groups (p > 0.05). P100 latency was found to increase significantly in comparison between the IGT and Control Group for both eyes (p right: 0.003, p left: 0.001) whereas it did not increase significantly in the comparison between the IFG and the Control Group (p right: 0.065, p left: 0.116). Conclusion: It was observed that VEP may be a parameter of predictive value that might be used in evaluating prediabetic cases in terms of retinopathies similar to DM.
  • No Thumbnail Available
    Item
    Clinicopathological Reflections of Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma Coexistence
    Akcura, C; Alkan, S; Güney, SC; Çavdar, GG; Senol, E; Tan, AY; Özdemir, N; Aydede, H; Hekimsoy, Z
    Objective: Papillary thyroid carcinoma (PTC) is the most common subtype of thyroid cancer. Hashimoto's thyroiditis (HT), a chronic inflammation of the thyroid gland, is one of the most common autoimmune diseases worldwide. In this study, we aimed to determine the relationship between PTC and HT and the clinicopathological effects of the combination of HT and PTC on the course of PTC. Methods: In this cross-sectional retrospective study, PTC cases who underwent surgery and were followed up at our institution's endocrinology outpatient clinic between 2014 and 2022 were divided into two groups according to the presence of HT. Demographic data of both groups, pathological features of the tumor, and preoperative laboratory findings were examined. Results: A total of 42.4% (n=118) of 278 cases were accompanied by HT. The mean age of the patients was 46.44 +/- 12.2 years. The majority of patients were female (80.6%, n=224). Multifocality was significantly less common in the HT group (p=0.037). Conclusion: Although multifocality was significantly less common in the HT group, no other statistically significant parameter was discovered in other clinicopathological findings. In light of these findings, the effect of HT on the course of PTC cannot be clearly determined. Considering the conflicting results regarding the effect of HT-PTC coexistence on the course of PTC in the literature, a comprehensive prospective study on this subject is necessary.